BioNTech develops mRNA cancer immunotherapies, next-generation immunomodulators and targeted therapies in oncology, and vaccines against infectious diseases.

BioNTech SE (/ biːˈɒntɛk / bee-ON-tek; or / baɪˈɒntɛk / bye-ON-tek[3] short for Biopharmaceutical New Technologies) is a German multinational biotechnology company headquartered in Mainz that …

17 hours ago · Pfizer and BioNTech previously announced that their jointly developed COVID-19 vaccine showed over 90% effectiveness in preventing infection based on initial trial data, although …

May 5, 2025 · BioNTech expects its revenues for the full 2025 financial year to be in the range of €1,700 - €2,200 million and revenue phasing similar to 2024, primarily concentrated in the last three to ...

Feb 3, 2025 · With the closing of the transaction, BioNTech will expand its capabilities to develop, manufacture and commercialize novel BNT327 combinations and next-generation bispecific antibodies

2 days ago · BioNTech SE is a German biotechnology company based in Mainz that focuses on the research, development, manufacture and marketing of immunological and RNA-based medicines …

BioNTech SE (BioNTech) is a biotechnology company that develops immunotherapies for cancer and infectious diseases.

Aug 8, 2025 · The deal helps move BioNTech’s proposed acquisition of CureVac closer to completion. With the settlement, GSK said it will tender the CureVac shares it owns in support of the $1.25 billion ...

1 day ago · Pharmaceutical giant Bayer has launched legal action against leading COVID-19 vaccine manufacturers Pfizer, BioNTech, and Moderna, alleging the misuse of its messenger RNA (mRNA) …

BioNTech is a global biopharmaceutical company pioneering novel investigative therapies for cancer and infectious diseases. We are committed to transforming how cancer is treated.